Derivative weighted active insulin control modelling and clinical trials for ICU patients.

Close control of blood glucose levels significantly reduces vascular complications in Type 1 and Type 2 diabetic individuals. Heavy derivative controllers using the data density available from emerging biosensors are developed to provide tight, optimal control of elevated blood glucose levels, while robustly handling variation in patient response. A two-compartment glucose regulatory system model is developed for intravenous infusion from physiologically verified subcutaneous infusion models enabling a proof-of-concept clinical trial at the Christchurch Hospital Department of Intensive Care Medicine. This clinical trial is the first of its kind to test a high sample rate feedback control algorithm for tight glucose regulation. The clinical trial results show tight control with reductions of 79-89% in blood glucose excursions for an oral glucose tolerance test. Experimental performance is very similar to modelled behaviour. Results include a clear need for an additional accumulator dynamic for insulin behaviour in transport to the blood and strong correlation of 10% or less between modelled insulin infused and the amounts used in clinical trials. Finally, the heavy derivative PD control approach is seen to be able to bring blood glucose levels below the (elevated) basal level, showing the potential for truly tight control.

[1]  G V Gill,et al.  Impaired subcutaneous absorption of insulin in 'brittle' diabetics. , 1982, Acta endocrinologica.

[2]  Vic Hasselblad,et al.  A clinical approach for the diagnosis of diabetes mellitus: an analysis using glycosylated hemoglobin levels. Meta-analysis Research Group on the Diagnosis of Diabetes Using Glycated Hemoglobin Levels. , 1996, JAMA.

[3]  E D Lehmann,et al.  Computer assisted diabetes care: a 6-year retrospective. , 1996, Computer methods and programs in biomedicine.

[4]  Ali Cinar,et al.  Simulation studies on the dynamics of diabetes mellitus , 2000, Proceedings IEEE International Symposium on Bio-Informatics and Biomedical Engineering.

[5]  M Schetz,et al.  Intensive insulin therapy in critically ill patients. , 2001, The New England journal of medicine.

[6]  Piero Marchetti,et al.  Phasic insulin release and metabolic regulation in type 2 diabetes. , 2002, Diabetes.

[7]  D Rodbard,et al.  A pharmacodynamic approach to optimizing insulin therapy. , 1991, Computer methods and programs in biomedicine.

[8]  L. González-Michaca,et al.  Insulin subcutaneous application vs. continuous infusion for postoperative blood glucose control in patients with non-insulin-dependent diabetes mellitus. , 2002, Archives of medical research.

[9]  T. Yoneyama,et al.  A robust controller for insulin pumps based on H-infinity theory , 1993, IEEE Transactions on Biomedical Engineering.

[10]  M. Fisher,et al.  A semiclosed-loop algorithm for the control of blood glucose levels in diabetics , 1991, IEEE Transactions on Biomedical Engineering.

[11]  C. Osmond,et al.  Understanding Oral Glucose Tolerance: Comparison of Glucose or Insulin Measurements During the Oral Glucose Tolerance Test with Specific Measurements of Insulin Resistance and Insulin Secretion , 1994, Diabetic medicine : a journal of the British Diabetic Association.

[12]  K. Teo,et al.  Optimal insulin infusion resulting from a mathematical model of blood glucose dynamics , 1989, IEEE Transactions on Biomedical Engineering.

[13]  A. S. Hodel,et al.  Automatic control issues in the development of an artificial pancreas , 1995, Proceedings of 1995 American Control Conference - ACC'95.

[14]  K. Hermansen,et al.  Differential impact of acute and chronic lipotoxicity on gene expression in INS-1 cells. , 2002, Metabolism: clinical and experimental.

[15]  C. Cobelli,et al.  A physiological simulation model of the glucose-insulin system , 1999, Proceedings of the First Joint BMES/EMBS Conference. 1999 IEEE Engineering in Medicine and Biology 21st Annual Conference and the 1999 Annual Fall Meeting of the Biomedical Engineering Society (Cat. N.

[16]  E. Ferrannini,et al.  Effect of acute hyperglycemia on insulin secretion in humans. , 2002, Diabetes.

[17]  Nicholas A. Peppas,et al.  Model predictive control for infusion pump insulin delivery , 1996, Proceedings of 18th Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

[18]  Z-H Lam,et al.  Active insulin infusion using optimal and derivative-weighted control. , 2002, Medical engineering & physics.

[19]  R. Bergman,et al.  Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. , 1981, The Journal of clinical investigation.

[20]  P. Wach,et al.  Neural predictive controller for insulin delivery using the subcutaneous route , 1998, IEEE Transactions on Biomedical Engineering.

[21]  John Pickup,et al.  Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes. , 2002, Diabetes care.

[22]  G. Charpentier,et al.  Management of drugs affecting blood glucose in diabetic patients with renal failure. , 2000, Diabetes & metabolism.

[23]  E. Kraegen,et al.  Blood Glucose Control by Intermittent Loop Closure in the Basal Mode: Computer Simulation Studies with a Diabetic Model , 1985, Diabetes Care.

[24]  R N Bergman,et al.  Assessment of insulin sensitivity in vivo. , 1985, Endocrine reviews.

[25]  J. Geoffrey Chase,et al.  Steady-state optimal insulin infusion for hyperglycemic ICU patients , 2002, 7th International Conference on Control, Automation, Robotics and Vision, 2002. ICARCV 2002..

[26]  C. Cobelli,et al.  Modeling glucose control on endogenous glucose production in nonsteady state: necessity of direct and delayed signalling , 1997, Proceedings of the 19th Annual International Conference of the IEEE Engineering in Medicine and Biology Society. 'Magnificent Milestones and Emerging Opportunities in Medical Engineering' (Cat. No.97CH36136).

[27]  J. Skyler,et al.  Algorithms for Adjustment of Insulin Dosage by Patients Who Monitor Blood Glucose , 1981, Diabetes Care.

[28]  Claudio Cobelli,et al.  Generalization of Map Estimation in SAAM II: Validation Against ADAPT II in a Glucose Model Case Study , 2004, Annals of Biomedical Engineering.

[29]  A. Guyton,et al.  Textbook of Medical Physiology , 1961 .

[30]  J. Geoffrey Chase,et al.  Active insulin infusion control of the blood glucose derivative , 2002, 7th International Conference on Control, Automation, Robotics and Vision, 2002. ICARCV 2002..

[31]  J. Mbanya,et al.  Diabetes in Africans. Part 2: Ketosis-prone atypical diabetes mellitus. , 2002, Diabetes & metabolism.

[32]  Claudio Cobelli,et al.  An integrated mathematical model of the dynamics of blood glucose and its hormonal control , 1982 .

[33]  O. McGuinness,et al.  Physiological consequences of phasic insulin release in the normal animal. , 2002, Diabetes.

[34]  V. Hasselblad,et al.  A clinical approach for the diagnosis of diabetes mellitus: an analysis using glycosylated hemoglobin levels. Meta-analysis Research Group on the Diagnosis of Diabetes Using Glycated Hemoglobin Levels. , 1996, JAMA.

[35]  F. Doyle,et al.  Control and modeling of drug delivery devices for the treatment of diabetes , 1995, Proceedings of 1995 American Control Conference - ACC'95.

[36]  R. Ollerton.  Application of optimal control theory to diabetes mellitus , 1989 .

[37]  C Cobelli,et al.  Stable-Label Intravenous Glucose Tolerance Test Minimal Model , 1989, Diabetes.

[38]  E D Lehmann,et al.  AIDA2: a Mk. II automated insulin dosage advisor. , 1993, Journal of biomedical engineering.

[39]  E R Carson,et al.  Computer-assisted diabetic management: a complex approach. , 1990, Computer methods and programs in biomedicine.

[40]  W. Tamborlane,et al.  Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes. , 1999, Diabetes care.